ClinicalTrials.gov
public full text
Public Domain
Prostate Cancer Antigen 3 (PCA-3) Gene Project
Nowadays, prostate cancer screening is largely widespread although it is not recommended yet. This screening includes primarily digital rectal examination and PSA. Recently, a new specific genetic marker of prostate cancer has been discovered. It is PCA-3 gene. The main objective is to evaluate prospectively this new marker in patients treated for prostatic pathology (benign or malign) in the department.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Detection of Clinically Significant Prostate Cancer Using Transperineal Targeted Biopsy Compared to Standard Transrectal Biopsy#802851
- Reliability and Interest of Circulating Tumor DNA in Endometrial Cancers.#1486566
- A Study of Drug Therapies for Salivary Gland Cancers Based on Testing of Genes#1443308
- Predictive and Prognostic Markers for Treatment Outcomes in Prostate Cancer Patients#1409712
- Label-free optical biomarker for prostate cancer diagnosis.#1158773
Record · ID 1498958
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive